Beginning with the work of J Pavlov, published in 1897, it has been known that levels of proteases and glycosidases in pancreatic juice were regulated in direct proportion to levels of protein and starch, respectively, in the diet. Pancreatic adaptation to nutritional substrates has been extensively studied at the level of tissue content' and at the level of biosynthesis of specific enzymes.2-5 From a study of normal, diabetic, and insulin-treated rats, Desnuelle first suggested that insulin is involved in the adaptation of amylase biosynthesis in response to changes in carbohydrates in the diet. Despite numerous studies however, which have documented the predominant role of secretin and cholecystokinin (CCK) in stimulating fluid, bicarbonate and enzyme secretion in the exocrine pancreas, the role of these peptide hormones in the regulation of protein synthesis and pancreatic adaptation was, until recently, largely unappreciated.
Because of rapid dedifferentiation of pancreatic acinar cells placed in tissue culture, it has not been possible to study under in vitro conditions, adaptive changes on normal isolated cells. By use ofcontinuous intravenous infusion of synthetic caerulein and secretin in optimal concentrations in the conscious rat we have been able to determine the limits of biochemical response to these hormones.68 After removal of the pancreas and incorporation of radiolabelled amino acids in the pancreatic lobules under in vitro conditions, separation of proteins by two dimensional IEF/SDS-gel electrophoresis has allowed a study of individual rates of synthesis for each of the exocrine products synthesised in the differentiated gland. An initial study' varying the content of protein and carbohydrate in the diet between 0 and 82%, respectively, keeping lipid constant, indicated that amylase and the majority of protease zymogens were synthesised in direct proportions to the nutritional substrates (Fig. 1 L -XI'--,*'. beginning at nine hours after FOY administration. The changes were similar to the ones previously observed with caerulein infusion (increase in the majority of protease forms, no change in lipase, and a decrease in amylase). After endogenous release of CCK, however, increase in the synthesis of anionic chymotrypsinogen (CI) was greater than that observed with anionic trypsinogen form 1 and 2.12 The opposite had been observed with caerulein infusion.9 It is noteworthy that a similar pattern of response as observed after FOY feeding has been found with the fastingrefeeding protocol. 13 The resolution obtained in the study of 16 exocrine products and in the pattern of their biosynthesis has allowed us to compare in detail changes observed during dietary adaptation with changes observed during hormonal stimulation. Although the information contained in the genetic code flows from DNA to RNA to protein, the events which regulate gene expression involve the interaction of regulatory proteins with specific nucleotide sequences on DNA.'" Thus synthesis of heterogenous RNA from limited regions of DNA is catalysed by the enzyme RNA polymerase II. This multimeric enzyme initiates the transcription process after binding to a specific region of DNA termed the promoter or TATA sequence, which usually resides 30 nucleotides upstream from the nucleotide at which transcription begins, the mRNA start site. After unwinding the DNA helix at the promoter site, RNA polymerase moves along the DNA and polymerises a single stranded mRNA sequence through the sequential addition of individual ribonucleotides. The efficiency of gene transcription initiated at the promoter site, however, is regulated by enhancer sequences, which usually reside further upstream in the 5' flanking region of genes. Enhancer elements occur in two types, one of which regulates the expression of genes in specific tissues and the other which modulates gene expression in response to hormones. 16 An understanding of how hormones regulate gene expression is largely confined to the action of steroid hormones. Studies from several laboratories have indicated that steroid hormone receptor proteins are DNA binding proteins."' Subdomains of the steroid receptor include a hormone binding site and a DNA binding site which interacts with specific nucleotide sequences in the enhancer regions of several genes whose expression is regulated by steroid hormones." The available evidence indicates that steroid hormones regulate gene expression at the level of transcription. In this case the changes observed in protein synthesis correlated with significant changes in mRNA levels and these in turn were correlated with changes in transcription rates of specific genes as determined by the use of complementary DNA probes. 8 In contrast little is known regarding the molecular mechanisms involved in gene expression by peptide hormones. In this area we have focused our research in the past years on studies relating to CCK and secretin stimulation in the rat exocrine pancreas. A consecutive study analysing functional mRNA concentrations in an in vitro translation system demonstrated that pronounced changes in individual enzyme biosynthesis were not accompanied by changes in levels of mRNA at least during the initial six hours of caerulein stimulation. 19 Consequently, we have suggested that during the early periods of caerulein stimulation, the anticoordinate changes observed in protein synthesis occur at the level of efficiency of mRNA translation. With continuation of caerulein stimulation for 12 or 24 hours, minor changes were observed in mRNA levels which paralleled those observed in protein synthesis. 20 Further research is needed to determine whether changes in mRNA levels during these late periods or after chronic hormone administration for several days are mediated by changes in transcription rates, mRNA turnover rates or both.2' Thus, with caerulein stimulation, there appears to be at least two distinct and overlapping phases in the regulation of gene expression. It is impressive that the anticoordinate changes observed in protein synthesis in both phases are similar and that regulations which occur in the second period serve to augment those occurring in the initial period. Sequential and overlapping regulation in this manner represents, at the biochemical level, increased commitment to adaptive changes.
The observation of a regulation of protein synthesis in the absence of changes in mRNA levels by peptide hormones poses the question about the regulatory mechanisms. Because of the relatively long half lives of mRNAs for exocrine pancreatic products, four to S Noncoding sequences Rat trypsinogen (pl=4 3) Dog trypsinogen (pI _4 7) Dog trypsinogen (pl=8-1) C CU UCUGCCA CCAUG AUACUUCUGCCAUCAUG IAI I I ACACCCCAGACCAGAU CCAGGGAGCAACCAUG 0 Potential stem-loop structure in 3'end of 18s rRNA (14 and 12 nucleotides, respectively) and show a region of conserved sequence involving nine contiguous and identical residues (Fig. 4) . In contrast, this conserved sequence was not observed among 29 nucleotides in the 5'-non-translated region of cationic trypsinogen mRNA. The conserved element in the two anionic trypsinogen mRNAs also showed potential base pairing to a region at the 3' end of 18S ribosomal RNA which exists in a stem-loop structure (Fig. 4) 
